GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Argenica Therapeutics Ltd (ASX:AGN) » Definitions » Other Current Payables

Argenica Therapeutics (ASX:AGN) Other Current Payables : A$0.00 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Argenica Therapeutics Other Current Payables?

Argenica Therapeutics's Other Current Payables for the quarter that ended in Dec. 2023 was A$0.00 Mil.

Argenica Therapeutics's quarterly Other Current Payables increased from Dec. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.04 Mil) but then declined from Jun. 2023 (A$0.04 Mil) to Dec. 2023 (A$0.00 Mil).

Argenica Therapeutics's annual Other Current Payables declined from Jun. 2021 (A$0.05 Mil) to Jun. 2022 (A$0.04 Mil) but then increased from Jun. 2022 (A$0.04 Mil) to Jun. 2023 (A$0.04 Mil).


Argenica Therapeutics Other Current Payables Historical Data

The historical data trend for Argenica Therapeutics's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Argenica Therapeutics Other Current Payables Chart

Argenica Therapeutics Annual Data
Trend Jun21 Jun22 Jun23
Other Current Payables
0.05 0.04 0.04

Argenica Therapeutics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Payables Get a 7-Day Free Trial - 0.04 - 0.04 -

Argenica Therapeutics Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Argenica Therapeutics Other Current Payables Related Terms

Thank you for viewing the detailed overview of Argenica Therapeutics's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Argenica Therapeutics (ASX:AGN) Business Description

Traded in Other Exchanges
N/A
Address
117 Broadway, Unit 4, Nedlands, WA, AUS, 6009
Argenica Therapeutics Ltd is engaged in the development and commercialization of novel drug candidates. Its ARG007 drug improves outcomes in pre-clinical stroke models and is in the process of being verified for its safety and toxicology before commencing Phase 1 clinical trials in humans.

Argenica Therapeutics (ASX:AGN) Headlines

No Headlines